Notice2023-22777
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 16, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 198 (Monday, October 16, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 198 (Monday, October 16, 2023)]
[Notices]
[Pages 71366-71367]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-22777]
[[Page 71366]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-1359]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``National Survey of Syringe Services
Programs (NSSSP)'', to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
May 4, 2023, to obtain comments from the public and affected agencies.
CDC received no public comments related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
The National Survey of Syringe Services Programs (NSSSP) (OMB
Control No. 0920-1359, Exp. 12/31/2024)--Revision--National Center for
HIV, Viral Hepatitis, STD, TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The primary purpose of the National Survey of Syringe Services
Programs (NSSSP) is to strengthen and improve the ability of CDC and
local and state partners to monitor and evaluate syringe services
programs (SSPs) nationally, with the overall goal of supporting,
sustaining, and improving SSPs nationwide and reducing infectious
disease and other harms related to drug use. Findings from the 2020-
2021 survey successfully characterized operational characteristics and
services, funding resources, community relations, and key operational
successes and challenges. The 2022 survey is currently being
implemented. Revisions are being requested to address the increasing
number of SSPs nationwide, the changing landscape of drug use
nationally, additional SSP supplies and services provided, and ways in
which SSPs are developing strategies to address the needs of people who
use drugs (PWUD).
The project will include all SSPs that are listed in a publicly
available directory of all known SSPs in the United States maintained
by the North American Syringe Exchange Network (NASEN; <a href="https://nasen.org">https://nasen.org</a>). The project will also include SSPs in NASEN's directory
that do not wish to be publicly listed but have agreed to be contacted
for research purposes, SSPs belonging to NASEN's buyers' club that are
not part of the directory, respondents to prior RTI Arnold Ventures
Surveys of SSPs that are not part of NASEN's directory, and other SSPs
proactively identified through searching state health department
websites, funding agencies, state and regional networks, regional
conferences, partner organization networks or webinars and via social
media. SSPs will be sent a letter of invitation to participate in a 35-
minute program survey. Participating programs will have the option of
completing the survey via different modalities to enhance feasibility
and comfort in completing the survey, for example via the Research
Electronic Data Capture (REDCap) or a similarly secure web-based
application. Other modalities for survey administration will include a
coordinated telephone or videoconferencing interview. SSPs will be sent
reminder letters for a six-month data collection period. SSPs that do
not respond to prior reminders will be sent one final reminder, and if
the SSP still does not want to participate, one (optional) question on
why the SSP did not complete the survey will be offered.
The survey will include questions on operational characteristics
and services, funding resources, community relations, and key
operational successes and challenges. Approximately 1000 SSPs will be
able to participate in the survey. CDC anticipates that 20% of SSPs
will decline to complete the survey, yielding 800 completed surveys per
year. However, given that it is challenging to predict future response
rates, we are requesting enough burden hours to allow 100% of SSPs to
respond to the survey. CDC estimates that it will take 35 minutes to
complete the survey, regardless of how the respondent chooses to
complete it (i.e., self-administered online or interviewer-administered
by phone or videoconferencing). CDC estimates that it will take SSPs
that do not respond to the initial survey invitation two minutes to
respond to the additional question.
CDC requests OMB approval for an estimated 616 annual burden hours.
There are no other costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondent Form Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs.............. National Syringe 1000 1 35/60
Services Program
Evaluation Survey.
[[Page 71367]]
Non-responding SSPs................. Non-Response Survey 1000 1 2/60
Item.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2023-22777 Filed 10-13-23; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on October 16, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.